Dopamine D3 Receptors Inhibit Hippocampal Gamma Oscillations by Disturbing CA3 Pyramidal Cell Firing Synchrony

Adham, 2014, Cariprazine demonstrates greater potency than aripiprazole in animal models of psychosis, cognitive impairment, and negative symptoms., Eur. Neuropsychopharmacol., 24, 10.1016/S0924-977X(14)70363-3

Andersson, 2012, Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors., Proc. Natl. Acad. Sci. U.S.A., 109, 13118, 10.1073/pnas.1201011109

Axmacher, 2010, Intracranial EEG correlates of expectancy and memory formation in the human hippocampus and nucleus accumbens., Neuron, 65, 541, 10.1016/j.neuron.2010.02.006

Bender, 2010, Dopaminergic modulation of axon initial segment calcium channels regulates action potential initiation., Neuron, 68, 500, 10.1016/j.neuron.2010.09.026

Bouthenet, 1991, Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA., Brain Res., 564, 203, 10.1016/0006-8993(91)91456-B

Buehlmann, 2008, The neuronal basis of attention: rate versus synchronization modulation., J. Neurosci., 28, 7679, 10.1523/JNEUROSCI.5640-07.2008

Çalişkan, 2015, Corticosterone and corticotropin-releasing factor acutely facilitate gamma oscillations in the hippocampus in vitro., Eur. J. Neurosci., 41, 31, 10.1111/ejn.12750

Cools, 2006, Reversal learning in Parkinson’s disease depends on medication status and outcome valence., Neuropsychologia, 44, 1663, 10.1016/j.neuropsychologia.2006.03.030

Fisahn, 2004, Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations., J. Neurosci., 24, 9658, 10.1523/JNEUROSCI.2973-04.2004

Fisahn, 1998, Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro., Nature, 394, 186, 10.1038/28179

Girgis, 2011, In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNO., Neuropsychopharmacology, 36, 887, 10.1038/npp.2010.228

Glickstein, 2005, Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention., Cereb. Cortex, 15, 1016, 10.1093/cercor/bhh202

Grace, 1991, Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia., Neuroscience, 41, 1, 10.1016/0306-4522(91)90196-U

Gross, 2013, Dopamine D3 receptor antagonism–still a therapeutic option for the treatment of schizophrenia., Naunyn Schmiedebergs Arch. Pharmacol., 386, 155, 10.1007/s00210-012-0806-3

Gulyás, 2010, Parvalbumin-containing fast-spiking basket cells generate the field potential oscillations induced by cholinergic receptor activation in the hippocampus., J. Neurosci., 30, 15134, 10.1523/JNEUROSCI.4104-10.2010

Gurevich, 1997, Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study., Arch. Gen. Psychiatry, 54, 225, 10.1001/archpsyc.1997.01830150047009

Hájos, 2009, Maintaining network activity in submerged hippocampal slices: importance of oxygen supply., Eur. J. Neurosci., 29, 319, 10.1111/j.1460-9568.2008.06577.x

Hamidovic, 2008, Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers., J. Clin. Psychopharmacol., 28, 45, 10.1097/jcp.0b013e3181602fab

Jönsson, 2003, Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis., Psychiatr. Genet., 13, 1, 10.1097/00041444-200303000-00001

Khan, 1998, Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain., J. Comp. Neurol., 402, 353, 10.1002/(SICI)1096-9861(19981221)402:3353::AID-CNE53.0.CO;2-4

Kiss, 2010, Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile., J. Pharmacol. Exp. Ther., 333, 328, 10.1124/jpet.109.160432

Klaft, 2012, Extracellular ATP differentially affects epileptiform activity via purinergic P2X7 and adenosine A1 receptors in naive and chronic epileptic rats., Epilepsia, 53, 1978, 10.1111/j.1528-1167.2012.03724.x

Kwon, 1999, Gamma frequency-range abnormalities to auditory stimulation in schizophrenia., Arch. Gen. Psychiatry, 56, 1001, 10.1001/archpsyc.56.11.1001

Laszy, 2005, Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats., Psychopharmacology (Berl), 179, 567, 10.1007/s00213-004-2096-z

Lee, 2010, Dysfunctional gamma-band activity during face structural processing in schizophrenia patients., Schizophr. Res., 119, 191, 10.1016/j.schres.2010.02.1058

Light, 2006, Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients., Biol. Psychiatry, 60, 1231, 10.1016/j.biopsych.2006.03.055

Lisman, 2013, The 𝜃-γ neural code., Neuron, 77, 1002, 10.1016/j.neuron.2013.03.007

Loiseau, 2009, Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists., Eur. Neuropsychopharmacol., 19, 23, 10.1016/j.euroneuro.2008.07.012

MacDonald, 2010, A decade of progress in the discovery and development of ’atypical’ antipsychotics., Prog. Med. Chem., 49, 37, 10.1016/S0079-6468(10)49002-5

Millan, 2012, Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy., Nat. Rev. Drug Discov., 11, 141, 10.1038/nrd3628

Missale, 1998, Dopamine receptors: from structure to function., Physiol. Rev., 78, 189, 10.1152/physrev.1998.78.1.189

Miyamoto, 2012, Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents., Mol. Psychiatry, 17, 1206, 10.1038/mp.2012.47

Mulert, 2011, Long-range synchrony of gamma oscillations and auditory hallucination symptoms in schizophrenia., Int. J. Psychophysiol., 79, 55, 10.1016/j.ijpsycho.2010.08.004

Nakajima, 2013, The potential role of dopamine D3 receptor neurotransmission in cognition., Eur. Neuropsychopharmacol., 23, 799, 10.1016/j.euroneuro.2013.05.006

Parikh, 2007, Prefrontal acetylcholine release controls cue detection on multiple timescales., Neuron, 56, 141, 10.1016/j.neuron.2007.08.025

Powell, 2014, Reduced gamma oscillations in a mouse model of intellectual disability: a role for impaired repetitive neurotransmission?, PLoS ONE, 9, 10.1371/journal.pone.0095871

Richtand, 1995, Regional quantification of D1, D2, and D3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay., Brain Res. Mol. Brain Res., 33, 97, 10.1016/0169-328X(95)00112-6

Rolls, 2013, The mechanisms for pattern completion and pattern separation in the hippocampus., Front. Syst. Neurosci., 7, 10.3389/fnsys.2013.00074

Rubin, 2014, The role of the hippocampus in flexible cognition and social behavior., Front. Hum. Neurosci., 8, 10.3389/fnhum.2014.00742

Schiller, 1995, Spatial profile of dendritic calcium transients evoked by action potentials in rat neocortical pyramidal neurones., J. Physiol., 487, 583, 10.1113/jphysiol.1995.sp020902

Schulz, 2012a, First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors., Br. J. Pharmacol., 167, 1480, 10.1111/j.1476-5381.2012.02107.x

Schulz, 2012b, Purinergic P2X, P2Y and adenosine receptors differentially modulate hippocampal gamma oscillations., Neuropharmacology, 62, 914, 10.1016/j.neuropharm.2011.09.024

Smith, 1999, The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset., Pharmacol. Biochem. Behav., 63, 201, 10.1016/S0091-3057(98)00230-5

Swant, 2008, Postsynaptic dopamine D3 receptor modulation of evoked IPSCs via GABAA receptor endocytosis in rat hippocampus., Hippocampus, 18, 492, 10.1002/hipo.20408

Szekeres, 2004, Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia., Am. J. Med. Genet. B Neuropsychiatr. Genet., 124B, 1, 10.1002/ajmg.b.20045

Tadori, 2011, Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors., Eur. J. Pharmacol., 666, 43, 10.1016/j.ejphar.2011.05.050

Talkowski, 2006, Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples., Biol. Psychiatry, 60, 570, 10.1016/j.biopsych.2006.04.012

Uhlhaas, 2010, Abnormal neural oscillations and synchrony in schizophrenia., Nat. Rev. Neurosci., 11, 100, 10.1038/nrn2774

Ukai, 1997, Effects of the dopamine D3 receptor agonist, R(+)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin, on memory processes in mice., Eur. J. Pharmacol., 324, 147, 10.1016/S0014-2999(97)00075-7

Watson, 2012, Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex., Neuropsychopharmacology, 37, 770, 10.1038/npp.2011.254

Womelsdorf, 2006, Gamma-band synchronization in visual cortex predicts speed of change detection., Nature, 439, 733, 10.1038/nature04258

Xing, 2010, Influence of dopamine D3 receptor knockout on age-related decline of spatial memory., Neurosci. Lett., 481, 149, 10.1016/j.neulet.2010.06.071